Entering text into the input field will update the search result below

Biotech AN2 Therapeutics files for IPO, developing treatment for rare lung disease

Mar. 04, 2022 5:17 PM ETBy: Val Brickates Kennedy, SA News Editor

IPO Initial Public Offering

Mikko Lemola/iStock via Getty Images

Biotech group AN2 Therapeutics (ANTX) has filed to hold an initial public offering to help fund development of its drug candidate for a rare lung disease.

The company said it intends to list its

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.